Vital Therapies (VTL) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts VTL Hot Sheet
Join SI Premium – FREE
Vital Therapies (NASDAQ: VTL) reported Q4 EPS of ($0.37), $0.01 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Vital Therapies (VTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
